By Kim Ramessa
LifeSignals Inc announces merger of LifeSignals portfolio with the connected health portfolio of Renew Health Limited to form LifeSignals Group Inc LifeSignals Inc., a global leader in the field of wireless biosensor technology through the Life Signal™ Processor silicon platform, announced its merger with the connected health assets of Renew Health Limited (Renew), based in…
By Kim Ramessa
We are delighted to be participating in the Heart Rhythm Congress at the ICC in Birmingham. We will be joining over 3,000 delegates attending a packed programme, covering the latest developments in the detection and treatment of cardiac arrhythmias, in particular, Atrial Fibrillation (AF). Come and visit us in the Main Hall, Stand S7…
By Kim Ramessa
In the UK alone there are over 1.2 million stroke survivors with two thirds of survivors leaving hospital with a disability. This leads to an estimated cost of £26 billion a year. It is estimated that 7,000 strokes could be prevented and over 2,000 lives saved every year in England if people with Atrial Fibrillation…
By Kim Ramessa
We are proud to participate in the annual congress of the European Heart Rhythm Association (EHRA), a branch of the European Society of Cardiology (ESC), that will be held 17 to 19 March at the Lisbon Congress Centre (CCL) in Portugal. EHRA 2019 will tackle “Implementing diagnostic and therapeutic innovations in daily practice” Dynamic…